No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹986.1Prev. Close
₹986.05Turnover(Lac.)
₹935.83Day's High
₹998.75Day's Low
₹96552 Week's High
₹1,015.752 Week's Low
₹570.75Book Value
₹78.28Face Value
₹1Mkt Cap (₹ Cr.)
15,965.95P/E
100.72EPS
9.62Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 15.41 | 15.21 | 5.07 | 5.07 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 652.37 | 460.66 | 281.31 | 423.54 |
Net Worth | 667.78 | 475.87 | 286.38 | 428.61 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Gross Sales | 1,284.27 | 853.89 | 393.52 | 313.57 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 1,284.27 | 853.89 | 393.52 | 313.57 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 3.63 | 18.5 | 25.48 | 16.85 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,891.3 | 103.97 | 4,53,750.23 | 705.44 | 0.85 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,858 | 70.79 | 1,82,116.76 | 598 | 0.44 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,469.2 | 67.75 | 1,51,313.88 | 577 | 0.13 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,401.9 | 30.6 | 1,13,225.36 | 384.64 | 0.93 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,318.5 | 34.17 | 1,10,037 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
CHANGAVALLI VENKAT
Executive Director & MD
PRATIBHA SUDHIR PILGAONKAR
Executive Director & CEO
PARAG SUGANCHAND SANCHETI
Non Executive Director
Varun Talukdar
Non Executive Director
Shantanu Rastogi
Non Executive Director
Anand Agarwal
Independent Non Exe. Director
K G Ananthakrishnan
Independent Non Exe. Director
MILIND ANIL PATIL
Company Sec. & Compli. Officer
DEEPASHREE OMKAR TANKSALE
Medone House B-75 Road No.33,
Wagle Estate,
Maharashtra - 400604
Tel: 022 6141 4000
Website: http://www.rubicon.co.in
Email: investors@rubicon.co.in
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as Rubicon Consultants Private Limited, with the RoC. Subsequently, the Companys name was changed from Rubicon Consultant...
Read More
Reports by Rubicon Research Ltd
What is the Rubicon Research Ltd share price today?
What is the Market Cap of Rubicon Research Ltd?
What is the PE and PB ratio of Rubicon Research Ltd?
What is the 52 Week High and Low of Rubicon Research Ltd?
What is the CAGR of Rubicon Research Ltd?
What is the shareholding pattern of Rubicon Research Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
